AVANDIA WARNING: FDA TO REQUIRE BLACK BOX WARNING OF INCREASED RISK OF HEART ATTACKS FOR AVANDIA USERS
On November 14, 2007 the FDA informed healthcare professionals of new information that was added to Avandia's black boxed warning. The FDA now requires that patients and physicians be warned of potential increased risk for heart attacks. The FDA felt compelled to act based upon a meta-analysis of the findings from 42 clinical studies that showed Avandia to be associated with an increased risk of myocardial ischemic events such as angina or myocardial infarction.
<?php include ("themes/drugsettlement/fp-drugform.inc"); ?>
The FDA has advised "people with type 2 diabetes who have underlying heart disease or who are at high risk of heart attack should talk to their healthcare professional about the revised warning as they evaluate treatment options".
This latest warning follows aggressive actions by Health Canada to restrict the use of Avandia to only those patients who are not adequately treated through diet, exercise and other monotherapy agents. Further the Canadian authority prohibits the use of Avandia for any patients who have ever experienced heart failure or are at increased risk of heart attack or heart failure.
Avandia has been linked to an increased risk of heart failure, heart attack and other cardiovascular problems when compared to other diabetic therapies.
If you or a loved one has suffered a heart attack, heart failure or other cardiovascular injury while taking Avandia please contact a DrugSettlement.com representative by filling out and sending the contact form. An experienced attorney will contact you to evaluate wheter you potential claim against the manufacturer for you injuries.
Lawsuits of Interest
- 1 of 4